Ardelyx, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARDX Nasdaq 2836 www.ardelyx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ardelyx, Inc.

Ardelyx, Inc.'s (NASDAQ:ARDX) Shift From Loss To Profit - Dec 10th, 2025 4:57 am
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript - Nov 27th, 2025 3:47 pm
Ardelyx Shares Surge After Regulatory Wins But Is the Stock Fully Priced in 2025? - Nov 19th, 2025 6:11 am
Can Ardelyx’s (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? - Nov 19th, 2025 2:13 am
A Look at Ardelyx (ARDX) Valuation Following Real-World XPHOZAH Study Results at Kidney Week - Nov 18th, 2025 11:17 pm
BTIG Maintains a Buy on Ardelyx, Inc (ARDX) - Nov 18th, 2025 3:07 am
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week - Nov 7th, 2025 2:05 pm
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London - Nov 5th, 2025 6:00 am
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference - Nov 4th, 2025 6:00 am
Why Ardelyx (ARDX) Is Up 20.2% After Positive IBSRELA Patient Data at ACG 2025 Conference - Nov 2nd, 2025 6:08 am
Ardelyx Inc (ARDX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Oct 30th, 2025 9:03 pm
Ardelyx (ARDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Oct 30th, 2025 4:30 pm
Ardelyx (ARDX) Reports Break-Even Earnings for Q3 - Oct 30th, 2025 3:40 pm
Ardelyx: Q3 Earnings Snapshot - Oct 30th, 2025 2:44 pm
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Oct 30th, 2025 2:01 pm
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting - Oct 28th, 2025 6:01 am
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week - Oct 21st, 2025 6:00 am
2 Overlooked Stocks to Snap Up in 2025 - Oct 16th, 2025 5:30 am
Will Ardelyx’s (ARDX) CFO Appointment Shape Its Growth Strategy as Its Portfolio Expands? - Oct 14th, 2025 6:09 am
Where Does Ardelyx Stand After Its Recent 24% Share Price Drop? - Oct 13th, 2025 11:03 pm